China Shineway Pharmaceutical Group Limited (CSWYY)

OTCMKTS · Delayed Price · Currency is USD

19.25

+0.72 (3.89%)

At close: May 13, 2025

Market Cap	789.14M -5.0%
Revenue (ttm)	392.15M -20.3%
Net Income	118.43M -2.9%
EPS	0.16 -2.3%
Shares Out	n/a
PE Ratio	6.66
Forward PE	7.02
Dividend	3.48 (18.09%)
Ex-Dividend Date	Sep 10, 2026

Volume	100
Open	19.25
Previous Close	18.53
Day's Range	19.25 - 19.25
52-Week Range	18.53 - 19.25
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About CSWYY

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 2,822

Stock Exchange OTCMKTS

Ticker Symbol CSWYY

Financial Performance

In 2025, CSWYY's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements